SOURCE: Myriad Genetics

March 06, 2008 06:30 ET

Myriad Genetics to Present at Cowen Health Care Conference on March 18, 2008

SALT LAKE CITY, UT--(Marketwire - March 6, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN), announced today that Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc., is scheduled to present an overview of the Company at the 28th Annual Cowen Health Care Conference, at 10:15 a.m. on March 18, at the Boston Marriott Copley Place in Boston, Massachusetts.

A live audio webcast of this presentation will be available online and can be accessed through a link on Myriad's home page at www.myriad.com.

Myriad Genetics, Inc. is a biopharmaceutical company focused on the development of novel healthcare products. The Company develops and markets predictive medicine products, and is developing and intends to market therapeutic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com.

Contact Information